featured
ASCO 2020: IDEA Final Analysis Reveals Most Patients with Stage III Colon Cancer Are Well-Served With 3 Months of Chemotherapy
A 6-month regimen greatly increases toxicity without substantial improvements in efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.